• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

横断面分析基线数据,以确定欧洲人群颈动脉内膜中层厚度的主要决定因素:IMPROVE 研究。

Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study.

机构信息

Department of Pharmacological Sciences, University of Milan, Italy.

出版信息

Eur Heart J. 2010 Mar;31(5):614-22. doi: 10.1093/eurheartj/ehp496. Epub 2009 Dec 1.

DOI:10.1093/eurheartj/ehp496
PMID:19952003
Abstract

AIMS

The 'IMPROVE study' was designed to investigate whether cross-sectional carotid artery intima-media thickness (IMT) and overall IMT progression are predictors of new vascular events in European individuals at high risk of cardiovascular diseases. This paper reports the results of the baseline analyses aimed at identifying the major determinants of increased carotid IMT (C-IMT).

METHODS AND RESULTS

IMPROVE is a prospective, multicentre, longitudinal, observational study. A total of 3711 subjects (age range 54-79 years) with at least three vascular risk factors (VRFs) were recruited in seven centres in Finland, France, Italy, the Netherlands, and Sweden. Collected variables included clinical, biochemical, genetic, socioeconomic, psychological, nutritional, and educational data, personal and family history of diseases, drug intake, and physical activity. By multiple linear regression analysis, C-IMT was positively associated with latitude, age, gender, pulse pressure, pack-years, and hypertension, and inversely with educational level (all P < 0.0001 for IMT(mean-max)). Latitude was the strongest independent determinant of C-IMT (partial r(2) for IMT(mean-max) = 0.109, P < 0.0001) and alone accounted for nearly half of the variation explained by the regression model (partial r(2) for IMT(mean-max) = 0.243, P < 0.0001). The geographical gradient for C-IMT paralleled the well-known north-to-south cardiovascular mortality gradient (r(2) for IMT(mean) = 0.96).

CONCLUSION

Latitude is an important determinant of C-IMT, which is not explained by between-country differences in established VRFs. Other unknown contributory mechanisms such as heritable, nutritional, or environmental factors may be important in the genesis of this geographical gradient.

摘要

目的

“改善研究”旨在研究颈动脉内中膜厚度(IMT)的横断面和整体 IMT 进展是否可预测欧洲心血管疾病高危人群中的新发血管事件。本文报告了旨在确定颈动脉 IMT(C-IMT)增加的主要决定因素的基线分析结果。

方法和结果

改善是一项前瞻性、多中心、纵向、观察性研究。在芬兰、法国、意大利、荷兰和瑞典的 7 个中心共招募了 3711 名(年龄 54-79 岁)至少有 3 个血管危险因素(VRFs)的受试者。收集的变量包括临床、生化、遗传、社会经济、心理、营养和教育数据、个人和家族病史、药物摄入和体力活动。通过多元线性回归分析,C-IMT 与纬度、年龄、性别、脉压、吸烟年数和高血压呈正相关,与教育水平呈负相关(所有 P < 0.0001 均为 IMT(mean-max))。纬度是 C-IMT 的最强独立决定因素(IMT(mean-max)的偏 r(2) = 0.109,P < 0.0001),单独解释了回归模型解释的近一半变异(IMT(mean-max)的偏 r(2) = 0.243,P < 0.0001)。C-IMT 的地理梯度与众所周知的从北到南的心血管死亡率梯度相吻合(IMT(mean)的 r(2) = 0.96)。

结论

纬度是 C-IMT 的重要决定因素,不能用国家间已确定的 VRF 差异来解释。其他未知的促成机制,如遗传性、营养性或环境因素,可能在这种地理梯度的形成中起重要作用。

相似文献

1
Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study.横断面分析基线数据,以确定欧洲人群颈动脉内膜中层厚度的主要决定因素:IMPROVE 研究。
Eur Heart J. 2010 Mar;31(5):614-22. doi: 10.1093/eurheartj/ehp496. Epub 2009 Dec 1.
2
Comparison of common carotid artery intima-media thickness between Brazilian Euro-descendants and Afro-descendants with atherosclerosis risk factors.比较有动脉粥样硬化危险因素的巴西欧裔和非裔个体的颈总动脉内膜中层厚度。
Clinics (Sao Paulo). 2009;64(7):657-64. doi: 10.1590/S1807-59322009000700009.
3
Segment-specific associations of carotid intima-media thickness with cardiovascular risk factors: the Coronary Artery Risk Development in Young Adults (CARDIA) study.颈动脉内膜中层厚度与心血管危险因素的节段特异性关联:年轻成人冠状动脉风险发展(CARDIA)研究。
Stroke. 2010 Jan;41(1):9-15. doi: 10.1161/STROKEAHA.109.566596. Epub 2009 Nov 12.
4
Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression.确诊的高血压前期受试者的颈动脉内膜中层厚度:预测因素与进展情况
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2244-9. doi: 10.1161/ATVBAHA.107.149641. Epub 2007 Jul 26.
5
Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study.颈动脉内膜中层厚度进展作为血管事件的预测指标:来自 IMPROVE 研究的结果。
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2273-9. doi: 10.1161/ATVBAHA.113.301844. Epub 2013 Jul 3.
6
Carotid artery intima media thickness, plaque and Framingham cardiovascular score in Asia, Africa/Middle East and Latin America: the PARC-AALA study.亚洲、非洲/中东和拉丁美洲的颈动脉内膜中层厚度、斑块与弗雷明汉心血管评分:PARC-AALA研究
Int J Cardiovasc Imaging. 2007 Oct;23(5):557-67. doi: 10.1007/s10554-006-9197-1. Epub 2006 Dec 21.
7
G-6A polymorphism of angiotensinogen gene modulates the effect of blood pressure on carotid intima-media thickness. The Bogalusa Heart Study.血管紧张素原基因的G-6A多态性调节血压对颈动脉内膜中层厚度的影响。博加卢萨心脏研究。
Am J Hypertens. 2007 Oct;20(10):1073-8. doi: 10.1016/j.amjhyper.2007.06.001.
8
Socioeconomic differences in progression of carotid intima-media thickness in the Atherosclerosis Risk in Communities study.社区动脉粥样硬化风险研究中颈动脉内膜中层厚度进展的社会经济差异
Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):411-6. doi: 10.1161/01.ATV.0000198245.16342.3d. Epub 2005 Dec 1.
9
Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients.在HIV-1感染患者中,颈动脉内膜中层厚度会随时间略有增加。
HIV Med. 2005 Nov;6(6):380-7. doi: 10.1111/j.1468-1293.2005.00324.x.
10
Effect of vascular risk factors on increase in carotid and femoral intima-media thickness. Identification of a risk scale.血管危险因素对颈动脉和股动脉内膜中层厚度增加的影响。危险评分的确定。
Atherosclerosis. 2011 May;216(1):109-14. doi: 10.1016/j.atherosclerosis.2011.01.034. Epub 2011 Feb 2.

引用本文的文献

1
Mechanistic Pathways Underlying Genetic Predisposition to Atrial Fibrillation Are Associated With Different Cardiac Phenotypes and Cardioembolic Stroke Risk.心房颤动遗传易感性的潜在机制途径与不同的心脏表型和心源性卒中风险相关。
Circ Genom Precis Med. 2025 Jun;18(3):e004932. doi: 10.1161/CIRCGEN.124.004932. Epub 2025 Jun 17.
2
Enhancing Cardiovascular Risk Prediction with a Simplified Carotid IMT Protocol: Evidence from the IMPROVE Study.采用简化颈动脉内膜中层厚度测量方案增强心血管风险预测:来自IMPROVE研究的证据。
Biomedicines. 2025 Feb 26;13(3):584. doi: 10.3390/biomedicines13030584.
3
Triglyceride-glucose index: carotid intima-media thickness and cardiovascular risk in a European population.
甘油三酯-葡萄糖指数:欧洲人群中的颈动脉内膜中层厚度与心血管风险
Cardiovasc Diabetol. 2025 Jan 13;24(1):17. doi: 10.1186/s12933-025-02574-2.
4
Determinants of Carotid Wall Echolucency in a Cohort of European High Cardiovascular Risk Subjects: A Cross-Sectional Analysis of IMPROVE Baseline Data.欧洲高心血管疾病风险人群队列中颈动脉壁回声强度的决定因素:IMPROVE基线数据的横断面分析
Biomedicines. 2024 Mar 26;12(4):737. doi: 10.3390/biomedicines12040737.
5
A machine learning based approach to identify carotid subclinical atherosclerosis endotypes.基于机器学习的方法识别颈动脉亚临床动脉粥样硬化表型。
Cardiovasc Res. 2023 Dec 19;119(16):2594-2606. doi: 10.1093/cvr/cvad106.
6
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention.CV-PREVITAL 研究的原理和设计:一项意大利多队列随机对照试验,旨在研究初级心血管预防中的创新数字策略。
BMJ Open. 2023 Jul 14;13(7):e072040. doi: 10.1136/bmjopen-2023-072040.
7
Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies.颈总动脉内中膜厚度与颈动脉斑块事件的关系:20 项前瞻性研究的个体参与者数据荟萃分析。
J Am Heart Assoc. 2023 Jun 20;12(12):e027657. doi: 10.1161/JAHA.122.027657. Epub 2023 Jun 10.
8
Can Surrogate Markers Help Define Cardiovascular Disease in Youth?替代标志物能否帮助界定青年人心血管疾病?
Curr Atheroscler Rep. 2023 Jun;25(6):275-298. doi: 10.1007/s11883-023-01101-6. Epub 2023 May 6.
9
Cross-Sectional Gene-Smoking Interaction Analysis in Relation to Subclinical Atherosclerosis-Results From the IMPROVE Study.横断面基因-吸烟相互作用分析与亚临床动脉粥样硬化的关系——来自 IMPROVE 研究的结果。
Circ Genom Precis Med. 2023 Jun;16(3):236-247. doi: 10.1161/CIRCGEN.122.003710. Epub 2023 Apr 6.
10
Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis-The IMPROVE Study.循环中前蛋白转化酶枯草溶菌素9(PCSK9)与亚临床动脉粥样硬化标志物之间的关系——IMPROVE研究
Biomedicines. 2021 Jul 19;9(7):841. doi: 10.3390/biomedicines9070841.